Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates

Biological Psychiatry

Volumn 54, Issue 2, 2003, Pages 105-110

  Castner, Stacy A ^a   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavioral sensitization; Hallucination; Monkey; Positive symptoms; Prefrontal lesion; Schizophrenia

Indexed keywords

AMPHETAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; BRAIN CORTEX LESION; BRAIN DYSFUNCTION; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SENSITIZATION; FEMALE; HALLUCINATION; LOW DRUG DOSE; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIMATE; PRIORITY JOURNAL;

EID: 0038108612     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(03)00292-0     Document Type: Article

References (45)

1. Buchanan R.W., Kirkpatrick B., Heinrichs D.W., Carpenter W.T. Clinical correlates of the deficit syndrome of schizophrenia. Am J Psychiatry. 147:1990;290-294.
2. Carpenter W.T., Heinrichs D.W., Wagman A.M.I. Deficit and nondeficit forms of schizophrenia The concept . Am J Psychiatry. 145:1988;578-583.
3. 123I]-IBZM equilibrium measurement of AMPH-induced dopamine release in rhesus monkeys. Neuropsychopharm. 22:2000;4-13.
4. Castner S.A., Goldman-Rakic P.S. Long-lasting psychotomimetic consequences of repeated low dose amphetamine exposure in rhesus monkeys. Neuropsychopharm. 20:1999;10-28.
5. Castner S.A., Goldman-Rakic P.S. Profound cognitive impairments in nonhuman primates exposed to amphetamine. Soc Neurosci Abstr. 25:1999;1563.
6. Castner S.A., Vosler P.S., Goldman-Rakic P.S. Lowered dopamine turnover in amphetamine-sensitized monkeys Development of a primate model of schizophrenia . Biol Psychiatry Abstr. 49:(suppl 8):2001;124S.
7. Clarke P.B.S., Jakubovic A., Fibiger H.C. Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine. Psychopharmacol. 96:1988;511-520.
8. Crow T.J. The two-syndrome concept Origins and current status . Schizophr Bull. 11:1985;471-485.
9. Ellinwood, EH Jr (1967): Amphetamine psychosis. I. Description of the individuals and process. J Nerv Ment Dis 144:273-283.
10. Ellinwood E.H. Jr, Sudilovsky A., Nelson L.M. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry. 130:1973;1088-1093.
11. Ellison G., Eison M.S. Continuous amphetamine intoxication An animal model of the acute psychotic episode . Psychol Med. 13:1983;751-761.
12. Ellison G., Nielsen E.B., Lyon M. Animal model of psychosis Hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication . J Psychiatry Res. 16:1981;13-22.
13. Haber S.N., Kunishio K., Mizobuchi M., Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci. 15:1995;4851-4867.
14. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:1975;507-522.
15. Kirkpatrick B., Buchanan R.W. The neural basis of the deficit syndrome of schizophrenia. J Nerv and Ment Disease. 178:1990;545-555.
16. Lennox B.R., Park S.B.G., Medley I., Morris P.G., Jones P.B. The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res Neuroimaging Section. 100:2000;13-20.
17. Levy R., Goldman-Rakic P.S. Association of storage and processing functions in the dorsolateral prefrontal cortex of the nonhuman primate. J Neurosci. 19:1999;5149-5158.
18. Liddle P.F., Lane C.J., Ngan E.T.C. Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus. Br J Psychiatry. 177:2000;402-407.
19. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia Deficits and dysfunction in neuronal regulation and plasticity . Neuropsychopharm. 17:1997;205-229.
20. Machiyama Y. Chronic methamphetamine intoxication model of schizophrenia in animals. Schizophr Bull. 18:1992;107-113.
21. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., et al. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharm. 17:1997;141-150.
22. McGuire P.K., Shah G.M.S., Murray R.M. Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet. 342:1993;703-706.
23. Miller D.D., Andreasen N.C., O'Leary D.S., Rezai K., Watkins G.L., Ponto L.L., et al. Effects of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology. 17:1997;230-240.
24. Miller M.H. Behavioral effects of amphetamine in a group of rhesus monkeys with lesions of dorsolateral frontal cortex. Psychopharmacology. 47:1976;71-74.
25. Ngan E.T.C., Lane C.J., Ruth T.J., Liddle P.F. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients Correlations with symptom change . J Neurol Neurosurg Psychiatry. 72:2002;106-110.
26. Nielsen E.B., Eison M.S., Lyon M., Iverson S.D. Hallucinatory behaviors in primates produced by around-the-clock amphetamine treatment for several days via implanted capsules. Prog Clin Biol Res. 131:1983;79-100.
27. Nielsen E.B., Lyon M., Ellison G. Apparent hallucinations in monkeys during around-the-clock amphetamine for seven to fourteen days. Possible relevance to amphetamine psychosis. J Nerv Ment Dis. 171:1983;222-233.
28. Ongur D., Price J.L. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys, and humans. Cereb Cortex. 10:2000;206-219.
29. Potkin S.G., Buchsbaum M.S., Jin Y., Tang C., Telford J., Friedman G., et al. Clozapine effects on glucose metabolic rate in striatum and frontal cortex. J Clin Psychiatry. 55:(suppl B):1994;63-66.
30. Ridley R.M., Baker H.F., Owen F., Cross A.J., Crow T.J. Behavioural and biochemical effects of chronic amphetamine treatment in the vervet monkey. Psychopharm. 78:1982;245-251.
31. Sabri O., Erkwoh R., Schreckenberger M., Owega A., Sass H., Buell U. Correlation of positive symptoms exclusively to hyperperfusion or hypoperfusion of cerebral cortex in never-treated schizophrenics. Lancet. 349:1997;1735-1739.
32. Sams-Dodd F., Newman J.D. Effects of administration regime on the psychotomimetic properties of d-amphetamine in the squirrel monkey (Saimiri sciureus). Pharmacol Biochem Behav. 56:1997;471-480.
33. Schlemmer R.F., Davis J.M. A comparison of three psychotomimetic-induced models of psychosis in nonhuman primate social colonies. Ethopharmacology Primate Models of Neuropsychiatric Disorder . 1983;33-78 Alan R. Liss, New York.
34. Selemon L.D., Goldman-Rakic P.S. Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci. 5:1985;776-794.
35. Shergill S.S., Brammer M.J., Williams S.C.R., Murray R.M., McGuire P.K. Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry. 57:2000;1033-1038.
36. Silbersweig D.A., Stern E., Frith C., Cahill C., Holmes A., Grootoonk S., et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:1995;176-179.
37. Snyder S.H. Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiat. 27:1972;169-178.
38. Snyder S.H. Amphetamine psychosis A "model" schizophrenia mediated by catecholamines . Am J Psychiatry. 130:1973;61-67.
39. Vita A., Bressi S., Perani D., Invernizzi G., Giobbio G.M., Dieci M., et al. High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naïve schizophrenic patients. Am J Psychiatry. 152:1995;876-882.
40. 18F]fluorodeoxyglucose (FDG). Eur Neuropsychopharm. 7:1997;9-24.
41. Vollenweider F.X., Leenders K.L., Scharfetter C., Maguire P., Stadelmann O., Angst J. Positron emission tomography and flurodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. Neuropsychopharm. 16:1997;357-371.
42. Walker A.E. A cytoarchitectural study of the prefrontal area of the macaque monkey. J Comp Neurol. 73:1940;59-86.
43. Whishaw I.Q., Fiorino D., Mittleman G., Castaneda E. Do forebrain structures compete for behavioral expression? Evidence from amphetamine-induced behavior, microdialysis, and caudate-accumbens lesions in medial frontal cortex damaged rats. Brain Res. 576:1992;1-11.
44. Wolf M.E., Dahlin S.L., Hu X.T., Xue C.J., White K. Effects of lesions of prefrontal cortex, amygdale, or fornix on behavioral sensitization to amphetamine Comparison with N-methyl-D-aspartate antagonists . Neurosci. 69:1995;417-439.
45. Yeterian E.H., Pandya D.N. Prefrontostriatal connections in relation to cortical architectonic organization in rhesus monkeys. J Comp Neurol. 312:1991;43-67.